JPMorgan Chase Financial Co. LLC Files 424B2 Prospectus

TL;DR

**JPM Chase Financial Co. just filed a prospectus for new securities.**

AI Summary

JPMorgan Chase Financial Co. LLC, a subsidiary of JPMorgan Chase & Co., filed a 424B2 prospectus on March 24, 2026. This filing is a pricing supplement for securities offered under their existing registration statement (File No. 333-270004-01). It matters to investors because it details the specific terms of new securities being offered, which can impact the company's capital structure and future financial performance, potentially affecting the value of existing shares.

Why It Matters

This filing outlines the terms of new securities offerings, which can influence JPMorgan Chase Financial Co. LLC's funding costs and overall financial health.

Risk Assessment

Risk Level: medium — The filing itself is administrative, but the underlying securities offering could introduce market or credit risk depending on its terms.

Analyst Insight

Investors should review the full pricing supplement (Document 1: PRICING SUPPLEMENT) to understand the specific terms, risks, and potential returns of the new securities being offered by JPMorgan Chase Financial Co. LLC, as this could impact the parent company's (JPMORGAN CHASE & CO) financial outlook.

Key Numbers

• 2026-03-24 — Filing Date (Date the 424B2 prospectus was filed)
• 333-270004-01 — File Number (Registration statement under which the securities are offered by JPMorgan Chase Financial Co. LLC)

Key Players & Entities

• JPMorgan Chase Financial Co. LLC (company) — Filer of the 424B2 prospectus
• JPMORGAN CHASE & CO (company) — Parent company of the filer
• 0001665650 (person) — CIK for JPMorgan Chase Financial Co. LLC
• 0000019617 (person) — CIK for JPMORGAN CHASE & CO
• 2026-03-24 (dollar_amount) — Filing Date
• 333-270004-01 (dollar_amount) — File Number for JPMorgan Chase Financial Co. LLC's registration statement

FAQ

Key Financial Figures

• $820,000 — l Company LLC Structured Investments $820,000 Review Notes Linked to the MerQube US
• $1,000 — f the notes. Minimum denominations of $1,000 and integral multiples thereof The no
• $44 — roceeds to Issuer Per note $1,000 $44 $956 Total $820,000 $36,080 $
• $956 — s to Issuer Per note $1,000 $44 $956 Total $820,000 $36,080 $783,920
• $36,080 — 1,000 $44 $956 Total $820,000 $36,080 $783,920 (1) See "Supplemental Use
• $783,920 — 4 $956 Total $820,000 $36,080 $783,920 (1) See "Supplemental Use of Proceeds
• $44.00 — l pay all of the selling commissions of $44.00 per $1,000 principal amount note it rec
• $904.10 — en the terms of the notes were set, was $904.10 per $1,000 principal amount note. See "
• $195.00 — ew Date Call Premium Amount First $195.00 Second $243.75 Third $292.50
• $243.75 — ium Amount First $195.00 Second $243.75 Third $292.50 Fourth $341.25
• $292.50 — $195.00 Second $243.75 Third $292.50 Fourth $341.25 Fifth $390.00
• $341.25 — $243.75 Third $292.50 Fourth $341.25 Fifth $390.00 Sixth $438.75 S
• $390.00 — $292.50 Fourth $341.25 Fifth $390.00 Sixth $438.75 Seventh $487.50
• $438.75 — h $341.25 Fifth $390.00 Sixth $438.75 Seventh $487.50 Eighth $536.25
• $487.50 — $390.00 Sixth $438.75 Seventh $487.50 Eighth $536.25 Ninth $585.00

Filing Documents

• form424b2.htm (424B2) — 204KB
• exfilingfees.htm (EX-FILING FEES) — 5KB
• image_001.jpg (GRAPHIC) — 21KB
• image_002.jpg (GRAPHIC) — 5KB
• image_006.jpg (GRAPHIC) — 159KB
• image_003.gif (GRAPHIC) — 3KB
• image_004.gif (GRAPHIC) — 5KB
• image_005.gif (GRAPHIC) — 5KB
• 0001918704-26-007920.txt ( ) — 570KB
• exfilingfees_htm.xml (XML) — 2KB

From the Filing

SUPPLEMENT March 20, 2026 Registration Statement Nos. 333-270004 and 333-270004-01; Rule 424(b)(2) JPMorgan Chase Financial Company LLC Structured Investments $820,000 Review Notes Linked to the MerQube US Tech+ Vol Advantage Index due March 25, 2031 Fully and Unconditionally Guaranteed by JPMorgan Chase & Co. The notes are designed for investors who seek early exit prior to maturity at a premium if, on any Review Date, the closing level of the MerQube US Tech+ Vol Advantage Index, which we refer to as the Index, is at or above the Call Value. The earliest date on which an automatic call may be initiated is March 24, 2027. Investors should be willing to forgo interest and dividend payments and be willing to lose up to 85.00% of their principal amount at maturity. The Index is subject to a 6.0% per annum daily deduction, and the performance of the Invesco QQQ Trust SM , Series 1 (the "QQQ Fund") is subject to a notional financing cost. These deductions will offset any appreciation of the components of the Index, will heighten any depreciation of those components and will generally be a drag on the performance of the Index. The Index will trail the performance of an identical index without such deductions. See "Selected Risk Considerations — Risks Relating to the Notes Generally — The Level of the Index Will Include a 6.0% per Annum Daily Deduction" and "Selected Risk Considerations — Risks Relating to the Notes Generally — The Level of the Index Will Include the Deduction of a Notional Financing Cost" in this pricing supplement. The notes are unsecured and unsubordinated obligations of JPMorgan Chase Financial Company LLC, which we refer to as JPMorgan Financial, the payment on which is fully and unconditionally guaranteed by JPMorgan Chase & Co. Any payment on the notes is subject to the credit risk of JPMorgan Financial, as issuer of the notes, and the credit risk of JPMorgan Chase & Co., as guarantor of the notes. Minimum denominations of $1,000 and integral multiples thereof The notes priced on March 20, 2026 and are expected to settle on or about March 25, 2026. CUSIP: 46660R7G3 Investing in the notes involves a number of risks. See "Risk Factors" beginning on page S-2 of the accompanying prospectus supplement, Annex A to the accompanying prospectus addendum, "Risk Factors" beginning on page PS-11 of the accompanying product supplement, "Risk Factors" beginning on page US-4 of the accompanying underlying supplement and "Selected Risk Considerations" beginning on page PS-5 of this pricing supplement. Neither the Securities and Exchange Commission (the "SEC") nor any state securities commission has approved or disapproved of the notes or passed upon the accuracy or the adequacy of this pricing supplement or the accompanying product supplement, underlying supplement, prospectus supplement, prospectus and prospectus addendum. Any representation to the contrary is a criminal offense. Price to Public (1) Fees and Commissions (2) Proceeds to Issuer Per note $1,000 $44 $956 Total $820,000 $36,080 $783,920 (1) See "Supplemental Use of Proceeds" in this pricing supplement for information about the components of the price to public of the notes. (2) J.P. Morgan Securities LLC, which we refer to as JPMS, acting as agent for JPMorgan Financial, will pay all of the selling commissions of $44.00 per $1,000 principal amount note it receives from us to other affiliated or unaffiliated dealers. See "Plan of Distribution (Conflicts of Interest)" in the accompanying product supplement. The estimated value of the notes, when the terms of the notes were set, was $904.10 per $1,000 principal amount note. See "The Estimated Value of the Notes" in this pricing supplement for additional information. The notes are not bank deposits, are not insured by the Federal Deposit Insurance Corporation or any other governmental agency and are not obligations of, or guaranteed by, a bank. Pricing supplement to product supplement no. 4-I dated April 13, 2023, underlying supplement no. 5-III dated March 5, 2025, the prospectus and prospectus supplement, each dated April 13, 2023, and the prospectus addendum dated June 3, 2024 Key Terms Issuer: JPMorgan Chase Financial Company LLC, a direct, wholly owned finance subsidiary of JPMorgan Chase & Co. Guarantor: JPMorgan Chase & Co. Index: The MerQube US Tech+ Vol Advantage Index (Bloomberg ticker: MQUSTVA). The level of the Index reflects a deduction of 6.0% per annum that accrues daily, and the performance of the QQQ Fund is subject to a notional financing cost that accrues daily. Call Premium Amount: The Call Premium Amount with respect to each Review Date is set forth below: first Review Date: 19.500% $1,000 second Review Date: 24.375% $1,000 third Review Date: 29.250% $1,000 fourth Review Date: 34.125% $1,000 fifth Review Date: 39.000% $1,000 sixth Review Date: 43.875% $1,000 seventh Review Date

View Full Filing

View this 424B2 filing on SEC EDGAR